drugset / Trial / NCT06530706

Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery

NCT06530706

Completed 185 enrolled Zhejiang Cancer Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate whether esketamine can relieve anxiety in patients undergoing abdominal tumor surgery.

Timeline

Start
2024-08-05
Primary completion
2025-05-30
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.1 mg/kg Intravenous
Subject Esketamine Other / unclassified 1 mg/kg Intravenous

Indications